Parallel Advisors’s Nektar Therapeutics NKTR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.2K | Sell |
1,053
-2
| -0.2% | -$52 | ﹤0.01% | 2030 |
|
2025
Q1 | $10.8K | Hold |
1,055
| – | – | ﹤0.01% | 2394 |
|
2024
Q4 | $14.7K | Hold |
1,055
| – | – | ﹤0.01% | 2250 |
|
2024
Q3 | $20.6K | Hold |
1,055
| – | – | ﹤0.01% | 2067 |
|
2024
Q2 | $19.6K | Hold |
1,055
| – | – | ﹤0.01% | 1980 |
|
2024
Q1 | $14.8K | Hold |
1,055
| – | – | ﹤0.01% | 2138 |
|
2023
Q4 | $8.94K | Hold |
1,055
| – | – | ﹤0.01% | 2334 |
|
2023
Q3 | $9.42K | Hold |
1,055
| – | – | ﹤0.01% | 2233 |
|
2023
Q2 | $9.1K | Hold |
1,055
| – | – | ﹤0.01% | 2207 |
|
2023
Q1 | $11.1K | Sell |
1,055
-66
| -6% | -$696 | ﹤0.01% | 2084 |
|
2022
Q4 | $38K | Sell |
1,121
-73
| -6% | -$2.47K | ﹤0.01% | 1399 |
|
2022
Q3 | $57K | Buy |
1,194
+15
| +1% | +$716 | ﹤0.01% | 1203 |
|
2022
Q2 | $67K | Buy |
1,179
+49
| +4% | +$2.79K | ﹤0.01% | 1116 |
|
2022
Q1 | $94K | Sell |
1,130
-38
| -3% | -$3.16K | ﹤0.01% | 1010 |
|
2021
Q4 | $237K | Buy |
1,168
+23
| +2% | +$4.67K | 0.01% | 673 |
|
2021
Q3 | $308K | Buy |
1,145
+25
| +2% | +$6.73K | 0.01% | 556 |
|
2021
Q2 | $288K | Sell |
1,120
-3
| -0.3% | -$771 | 0.01% | 547 |
|
2021
Q1 | $337K | Buy |
1,123
+4
| +0.4% | +$1.2K | 0.02% | 458 |
|
2020
Q4 | $285K | Sell |
1,119
-27
| -2% | -$6.88K | 0.02% | 474 |
|
2020
Q3 | $285K | Buy |
1,146
+82
| +8% | +$20.4K | 0.02% | 438 |
|
2020
Q2 | $369K | Sell |
1,064
-3
| -0.3% | -$1.04K | 0.02% | 367 |
|
2020
Q1 | $285K | Buy |
1,067
+18
| +2% | +$4.81K | 0.02% | 361 |
|
2019
Q4 | $340K | Buy |
1,049
+5
| +0.5% | +$1.62K | 0.03% | 366 |
|
2019
Q3 | $285K | Hold |
1,044
| – | – | 0.02% | 380 |
|
2019
Q2 | $557K | Buy |
1,044
+4
| +0.4% | +$2.13K | 0.05% | 217 |
|
2019
Q1 | $524K | Hold |
1,040
| – | – | 0.06% | 213 |
|
2018
Q4 | $512K | Hold |
1,040
| – | – | 0.07% | 183 |
|
2018
Q3 | $951K | Sell |
1,040
-2
| -0.2% | -$1.83K | 0.12% | 138 |
|
2018
Q2 | $763K | Buy |
1,042
+5
| +0.5% | +$3.66K | 0.11% | 138 |
|
2018
Q1 | $1.65M | Buy |
+1,037
| New | +$1.65M | 0.26% | 70 |
|